Baclofen as a Cocaine Anti-Craving Medication: A Preliminary Clinical Study

被引:0
|
作者
Walter Ling
Steven Shoptaw
Dorota Majewska
机构
[1] Los Angeles Addiction Treatment Research Center (LAATRC),
[2] National Institute on Drug Abuse/Medications Development Division,undefined
关键词
D O I
10.1016/S0893-133X(97)00128-0
中图分类号
学科分类号
摘要
引用
收藏
页码:403 / 404
页数:1
相关论文
共 50 条
  • [1] Baclofen as a cocaine anti-craving medication: A preliminary clinical study
    Ling, W
    Shoptaw, S
    Majewska, D
    [J]. NEUROPSYCHOPHARMACOLOGY, 1998, 18 (05) : 403 - 404
  • [2] Clinical trials with anti-craving drugs
    Soyka, M
    Hollweg, M
    Preuss, U
    Schutz, C
    [J]. NERVENHEILKUNDE, 1996, 15 (08) : 473 - 478
  • [3] Baclofen as an anti-craving agent for adolescent inhalant dependence syndrome
    Kandasamy, Arun
    Jayaram, Naveen
    Benegal, Vivek
    [J]. DRUG AND ALCOHOL REVIEW, 2015, 34 (06) : 696 - 697
  • [4] Baclofen from an 'anti-craving' agent to 'craved for' drug: A case report
    Sharma, Rachit
    Rani, Usha, V
    Benedict, Shyla H. M.
    [J]. INDIAN JOURNAL OF PSYCHIATRY, 2023, 65 (04) : 489 - 491
  • [5] ANTI-CRAVING DRUG AND THE STRUCTURE OF CRAVING
    Miyata, H.
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2018, 42 : 131A - 131A
  • [6] Role of Acamprosate and Baclofen as Anti-craving Agents in Alcohol Use Disorder: A 12-Week Prospective Study
    Sharma, Akhilesh K.
    Rikhari, Praveen
    Shukla, Alok K.
    Rikhari, Pragya
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (04)
  • [7] Anti-craving biofeedback program in clinical course of pathological addictions
    Sosin, I.
    Chuev, Y.
    Volkov, A.
    Goncharova, O.
    [J]. EUROPEAN PSYCHIATRY, 2017, 41 : S879 - S879
  • [9] Neurobiology of new anti-craving drugs
    Spanagel, R
    Hölter, SM
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R588 - R588
  • [10] Anti-craving effects of environmental enrichment
    Thiel, Kenneth J.
    Sanabria, Federico
    Pentkowski, Nathan S.
    Neisewander, Janet L.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2009, 12 (09): : 1151 - 1156